约翰·查恩利奖:人类白细胞抗原基因型对全髋关节置换术后细菌感染率及成功根除的影响
该回顾性匹配病例对照研究纳入49例初次全髋关节置换术患者(23例假体周围感染,26例对照),中位随访8.5年,采用高分辨率基因分析检测11个HLA位点。发现HLA-C*06:02、HLA-DQA1*04:01和HLA-DQB1*04:02为感染风险等位基因,HLA-C*03:04为保护性等位基因;未发现与治疗成功或失败相关的HLA等位基因。作者认为这是首个证明HLA基因型与假体周围感染相关的研究,需更大规模研究验证。
要点
- HLA-C*06:02与假体周围感染风险相关(OR 5.25,95%CI 0.96-28.6,P=.064)。
- HLA-C*03:04为保护性等位基因(OR 0.12,95%CI 0.01-1.10,P=.052)。
- 未发现与假体周围感染治疗成功或失败相关的HLA等位基因。
核心结论
- 本研究提示全髋关节置换术后假体周围感染的发生与某些HLA风险等位基因和保护等位基因相关。
- 据作者所知,这是首个证明患者HLA基因型与假体周围感染发生相关的研究。
- 作者认为需要并值得开展更大规模的研究。
研究设计与样本
- 回顾性、匹配的病例对照研究,使用单中心前瞻性收集的数据。
- 共纳入49例初次全髋关节置换术患者,平均随访8.5年(范围4.2至12.9年)。
- 23例假体周围感染病例与26例无感染对照按年龄、性别、随访时间、体重指数、主要诊断和合并症匹配(P > .05)。
- 对所有患者血清样本进行靶向11个HLA位点的高分辨率基因分析,比较组间HLA基因频率和携带率。
- 对假体周围感染治疗成功(18例)与失败(5例)进行亚组分析;遗传分析统计显著性设为P = .10,其他分析设为0.05。
主要发现
- 有4个HLA等位基因与假体周围感染发生显著相关。
- 3个风险等位基因包括HLA-C*06:02(比值比5.25,95%CI 0.96至28.6,P = .064)、HLA-DQA1*04:01(P = .096)和HLA-DQB1*04:02(P = .096)。
- 唯一的保护性等位基因是HLA-C*03:04(比值比0.12,95%CI 0.01至1.10,P = .052)。
- 未发现与治疗成功或失败相关的特定HLA等位基因。
关键数值与推荐
- HLA-C*06:02:比值比5.25,95%CI 0.96至28.6,P = .064。
- HLA-DQA1*04:01:P = .096。
- HLA-DQB1*04:02:P = .096。
- HLA-C*03:04:比值比0.12,95%CI 0.01至1.10,P = .052。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论指出需要并值得开展更大规模的研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genetics play an important role in several medical domains; however, the influence of human leukocyte antigen (HLA) genotype on the development of periprosthetic joint infection (PJI) in total hip arthroplasty (THA) remains unknown. The primary aim of this study was to determine if HLA genotype is associated with the development of bacterial PJI in THA. Secondarily, we evaluated the association between HLA genotype and PJI treatment success. METHODS: A retrospective, matched, case-control study was performed using prospectively collected data from a single institution. A total of 49 patients who underwent primary THA were included, with a mean follow-up of 8.5 years (range, 4.2 to 12.9). The 23 cases (PJI) and 26 controls (no PJI) were matched for age, sex, follow-up, body mass index, primary diagnosis, and comorbidities (P > .05). High-resolution genetic analysis targeting 11 separate HLA loci was performed in all patients using serum samples. The HLA gene frequencies and carriage rates were determined and compared between cohorts. A subgroup analysis of PJI treatment success (18) and failure (5) was performed. Statistical significance was set at P = .10 for genetic analysis and at 0.05 for all other analyses. RESULTS: There were 4 HLA alleles that were significantly associated with the development of PJI. The 3 at-risk alleles included HLA-C∗06:02 (odds ratio 5.25, 95% CI [confidence interval] 0.96 to 28.6, P = .064), HLA-DQA1∗04:01 (P = .096), and HLA-DQB1∗04:02 (P = .096). The single protective allele was HLA-C∗03:04 (odds ratio 0.12, 95% CI 0.01 to 1.10, P = .052). There were no specific HLA alleles that were associated with treatment success or failure. CONCLUSIONS: This study suggests that there are at-risk and protective HLA alleles associated with the development of PJI in THA. To our knowledge, this is the first study to demonstrate an association between patient HLA genotype and the development of PJI. A larger study of the subject matter is necessary and warranted.
引用
- Neufeld ME, Sheridan GA, MacDonell T, et al. The John Charnley Award: The Impact of Human Leukocyte Antigen Genotype on Bacterial Infection Rates and Successful Eradication in Total Hip Arthroplasty. J Arthroplasty. 2024. PMID: 38830432. doi:10.1016/j.arth.2024.05.076
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。